ADAR1 Capital Management »

Churchill Cap Corp X shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Churchill Cap Corp X (CCCX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Churchill Cap Corp X

Tip: Access up to 7 years of quarterly data

All positions including Churchill Cap Corp X held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Churchill Cap Corp X by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 65k 15.60

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Churchill Cap Corp X

Empyrean Capital Partners
Susquehanna International
D. E. Shaw & Co
QVT Financial
Magnetar Financial
Two Sigma Investments
Moore Capital Management
Millennium Management
Jane Street
Alberta Investment Management Corporation
Leonteq Securities
Polar Securities
Plustick Management
Rivernorth Capital Management
Tenor Capital Management

View all funds holding Churchill Cap Corp X